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ABSTRACT
Objective:  The objective of the study was to determine 
factors contributing to acceptability of Highly Active 
Anti-Retro Therapy (HAART) by HIV-positive clients 
co-infected with tuberculosis accessing care at health 
facilities in Livingstone district, Zambia.
Design:  An explorative descriptive design study was 
conducted at three major chest clinics in Livingstone; 
namely Livingstone General Hospital, Mahatma Gandhi 
and Sepo health centers. The study population was all the 
TB/HIV co-infected patients aged between 18 and 49 
years who were referred for HAART in the previous one 
month or more prior to the study and were not critically 
ill. The respondents were selected using systematic 
sampling method. A total number of 131 TB/HIV co-
infected patients who were being attended to at the 
selected chest clinics in Livingstone were enrolled into 
the study. 
Data were collected using a structured interview schedule 
and focus group discussion guide to enable the 
investigator collect both quantitative and qualitative data. 
Epi-info version 6 and SPSS 12.0 for windows software 
computer packages were used to analyze the quantitative 
data. Chi-square was used to measure association 
between the dependent variable (acceptability of HAART 
by TB patients) and the independent variables. With the 
confidence interval set at 95%, the p value was used to 
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ascertain the degree of significance by using the decision 
rule which rejects the null hypothesis if p value is equal or 
less than 0.05.
Results:  This study revealed that the most significant 
factors associated with acceptability of HAART by TB 
patients and accessibility of HAART were knowledge of 
TB and HIV relationship including HAART, HIV-related 
stigma and discrimination and support from health care 
providers regarding HAART.
A significant association was found between knowledge 
of TB and HIV relationship and safety of taking HAART 
while on TB treatment, 77.9% of the respondents who did 
not know the relationship between TB and HIV indicated 
that it was not safe to take HAART concurrently with TB 
treatment (p value 0.000). 
There was also significant association knowledge of 
commencement of HAART in TB patients and discussion 
of HAART and its benefits with the counselor. Of the 52 
respondents who did not know that HAART could be 
commenced in TB patients, majority (71.2%) did not 
discuss HAART and its benefits with the counselor (p 
value 0.001). 
In addition, there was a significant association between 
HIV-related stigma and discrimination and acceptability 
of HAART. Majority (78.7%) of the respondents who 
were treated differently because of HIV reported that they 
would not go back to the ART clinic for medication (p 
value 0.002). Furthermore, respondents whose HAART 
concerns were not addressed (74.1%) would not go back 
to the ART clinic for HAART (p value 0.008). 
The results further showed that factors such as TB-related 
stigma and discrimination, sex, age, marital status and 
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level of education were not significantly associated with 
acceptability of HAART. Probably, TB-related stigma 
and discrimination is not associated to acceptability of 
HAART because TB is curable. The demographic 
characteristics were also not associated with acceptability 
of HAART probably because of personality attributes of 
an individual.
Conclusion:  From this study, it is evident that there are 
certain factors that are significantly associated with low 
acceptability of HAART by TB patients. These factors 
include TB patients' level of knowledge on TB/HIV co-
infection and HAART, TB- and HIV-associated stigma 
and discrimination, amount and depth of information 
provided to the TB patient during the pre- and post-test 
counseling and provision of support to TB patients by 
health care providers. 
The other factors identified to be associated with 
acceptability of HAART by TB patients were integration 
of the TB and HIV services and number of health facilities 
offering the TB and HIV services. Most of the clients 
indicated that integration of TB and HIV services will be 
beneficial to them as it limits the number of time spent in 
these facilities, minimizes the cost of travelling to the 
sites and allows them more time to rest.
The study further revealed that certain factors were not 
associated with acceptability of HAART in this study. 
These factors were sex, age, marital status and 
educational level of respondents. However, in similar 
studies, these factors were found to be statistically 
significant to acceptability of HAART by patients co-
infected with TB/HIV.
As revealed from this study, the burden of being 
diagnosed with concurrent TB and HIV infections on 
individuals can be lessened by uptake of HAART. This in 
turn will have a positive impact on the development of the 
nation.
INTRODUCTION
The convergence of Tuberculosis (TB) and Human 
Immuno Deficiency Virus (HIV) epidemics is a deadly 
threat to gains in survival among populations¹. TB is also 
one of the most common causes of morbidity and one of 
the leading causes of mortality in People Living with HIV 
and AIDS². Currently, about 42 million people are HIV 
infected and almost one third are also infected with TB 
worldwid³. The dual epidemics are particularly pervasive 
in Africa, where HIV has been the single most important 
factor contributing to the incidence of TB over the last 10 
years. Approximately, 50% of patients with active TB 
disease in many African countries are HIV positive³.
In Zambia, approximately 70% of the people with TB are 
co-infected with HIV². Several important associations 
between epidemics of HIV and TB especially if untreated 
contribute to the high morbidity and mortality rates 
among people who are dually infected. Some of these 
associations include:
·HIV positive persons are more susceptible to 
exogenous re-infection by a second strain of TB, 
even after adequate anti-TB treatment has been 
provided
·The risk of poor response to TB treatment, that 
is, failure, relapse and death is greater among 
HIV positive individuals
·Once a person who has HIV develops active TB, 
the progression to AIDS and death is more rapid 
than for HIV positive patients who do not have 
active TB because TB enhances replication of 
HIV³.
With the large and rising numbers of HIV clients co-
infected with TB, health services struggle to cope leading 
3,4to the following compounding consequences :
·Difficulties in diagnosis of TB. This is because 
as HIV related immunosuppression increases, 
the clinical pattern of TB changes, with 
increasing numbers of smear-negative and extra 
pulmonary cases. In addition, TB is more likely 
to be disseminated
·HIV infected TB patients can also suffer from 
other HIV-related diseases
·I n a d e q u a t e  s u p e r v i s i o n  o f  a n t i - T B  
chemotherapy
·High mortality rates during treatment
·High default rates because of adverse drug 
reactions due to the use of second line anti-TB 
drugs
·High rates of TB recurrence
·Nosocomial infections
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Owing to the high percentage of HIV positive patients co-
infected with TB in Zambia, the majority of the 
populations are at a greater risk of dying unless the 
TB/HIV control measures such as ensuring acceptability 
of HAART by TB patients are supported Furthermore, 
TB is the only major AIDS-related opportunistic infection 
4that poses a risk to HIV negative people .
Thus, in response to the burden of TB/HIV co-infection 
on both individuals and populations, WHO established 
the TB/HIV working group of the Stop TB Partnership in 
2001 with the aim of coordinating the global response to 
3the HIV associated TB epidemic . A policy which states 
that all HIV patients should be screened for both active 
and latent TB was then formulated. Further, the policy 
states that all active TB patients regardless of their 
perceived risk of HIV infection should be offered an HIV 
test as part of their TB treatment package and as part of the 
control of TB and HIV in the community. When the two 
screening services are provided concomitantly, a greater 
number of co-infected individuals are identified, 
increasing the likelihood of achieving improved 
outcomes for both diseases. The screening services are 
entry points to the control and treatment of both 
infections. One of the notable control strategies for TB 
and HIV infections is the acceptability and consequent 
uptake of HAART prescribed to patients suffering from 
the dual epidemics. Evidence of success stories of 
outcome of the treatment of the two diseases have been 
reported in Latvia and Peru where HAART was started 
5early in TB patients . Improvement in the immune 
function was noted in People Living with HIV and AIDS 
(PLWHA).
Uptake of HAART by TB/HIV positive patients also 
reduces the incidence rates of TB in the community, 
thereby reducing the risk of transmission of TB to the 
entire community including HIV negative people. This is 
because TB is an airborne disease and TB/HIV co-
infected persons have a lower chance of TB recurrence if 
4HAART is utilized . In addition, the burden of TB/HIV 
co-infection put on the health care system in terms of re-
admissions of patients, treatment with anti-TB drugs and 
the use of other services such as laboratory tests and 
transfusion can be averted by simply supporting TB 
patients who are eligible for HAART so that they accept 
and consequently utilize this service effectively. 
. 
 
It is for this reason that the study investigated the factors 
influencing acceptability of HAART by HIV patients co-
infected with TB. Investigating these factors has great 
potential for increasing access of HAART to TB/HIV co-
infected individuals which will ultimately lessen the 
burden of the two infections on individuals, communities 
and the country at large.
METHODOLOGY
Study Design and Sampling
The study used an explorative descriptive design and was 
conducted at three major chest clinics in Livingstone; 
namely Livingstone General Hospital, Mahatma Gandhi 
and Sepo health centers. The study population was all the 
TB/HIV co-infected patients aged between 18 and 49 
years who were referred for HAART in the previous one 
month or more prior to the study and were not critically ill. 
The respondents were selected using systematic sampling 
method. A total number of 131 TB/HIV co-infected 
patients who were being attended to at the selected chest 
clinics in Livingstone were enrolled into the study. Out of 
the 230 population size, 131 respondents were selected 
using systematic sampling method. The inclusion criteria 
for this study was all the TB/HIV co-infected patients aged 
between 18 and 49 years who were referred for HAART in 
the previous one or more month(s) prior to the study and 
were not critically ill as long as they had been residing in 
Livingstone district for 6 months or more and were willing 
to participate in the study. The respondents were selected 
using systematic sampling method.
Data Collection Tools
A structured interview schedule was used as a checklist 
while a focus group discussion guide was used to guide the 
interview during data collection. The structured interview 
schedule comprised of questions that were both open and 
closed ended. Using the interview schedule, the researcher 
and assistants interviewed 131 respondents. A focus group 
guide was also used to ask questions to a group consisting 
of 6 – 12 participants. The researcher and assistants 
conducted two focus group discussions at each of the three 
ART sites, thus a total number of six focus group 
discussions were conducted.
C o n f i d e n t i a l i t y  w a s  a s s u r e d  t o  t h e  
respondents/participants and their consent obtained 
before commencing the interviews.
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Data Analysis
Epi-info version 6 and SPSS 12.0 for windows software 
computer packages were used to analyze data from the 
interview schedule. Chi-square was used to measure 
association between the dependent variable (acceptability 
of HAART by TB patients) and the independent variables. 
With the confidence interval set at 95%, the p value was 
used to ascertain the degree of significance by using the 
decision rule which rejects the null hypothesis if p value is 
equal or less than 0.05.
Content analysis was used to analyze data from the focus 
group discussion. The participants' own words were used 
to list the key statements and ideas expressed for each 
topic of discussion. The most useful information that 
emerged from the discussions was selected to illustrate the 
main ideas. The findings were then interpreted and a full 
report of the focus group discussion that reflected the 
discussion as much as possible was prepared. 
RESULTS AND DISCUSSIONS
Knowledge of TB/HIV and HAART
The findings revealed that knowledge level on TB and 
HIV relationship among the majority of the respondents 
(71.9%) was low although almost all the respondents 
(97.7%) had heard about TB and HIV. The low level of 
knowledge on Tb and HIV relationship was attributed to 
the fact most of the TB and HIV services in Zambia are not 
integrated. Therefore, the TB site could offer services that 
emphasise more on the management of TB disease while 
on the other hand, the ART site could also emphasise on 
the management of HIV infection. 
Significantly, more respondents with inadequate 
knowledge on TB and HIV relationship (77.9%) were of 
the opinion that it was not safe to take HAART 
concurrently with TB treatment than those with adequate 
knowledge (55.6%) (p value 0.000). One possible 
explanation for this could be that knowledge of the 
relationship between TB and HIV influences acquiring 
more knowledge on the safety of taking HAART 
concurrently with TB medication. The assumption is that 
adequate knowledge on TB and HIV relationship can 
motivate one to acquire more knowledge on interventions 
that can remedy the situation such as the utilization of 
HAART and how to ensure safety when taking ARVs.
HIV-related Stigma and Discrimination
The study revealed that stigma and discrimination among 
TB patients infected with HIV is still very high in 
government health facilities despite the various measures 
that the country has put in place to fight stigma and 
discrimination such as re-training of service providers. 
Most (93.3%) of the respondents who were aware that 
they were co-infected with TB and HIV felt that the health 
workers treated them differently because they had HIV 
infection in addition to the TB. The several ways in which 
the health workers treated them differently were that most 
of the health workers showed no concern (64.3%), some 
of the health workers did not look at them properly 
(21.4%) and 14.3% were harsh to the patients. 
The above responses are similar to what some participants 
in the focus group discussion said. One participant said 
that the nurses just lock themselves in the office without 
checking on them when the patients are admitted in 
hospital. The other participant said that some nurses are 
harsh and need to be talked to. This could be attributed to 
the association of TB disease to HIV infection as reported 
by the MOH (2006) that in Zambia, approximately 70% 
of the TB patients are co-infected with HIV. The findings 
are similar to those revealed in a study that was conducted 
by Mthetwa (2004) in South Africa. His study revealed 
that such patients felt undermined by the behaviour of the 
health professionals because of the manner in which 
HIV/TB co-infected patients were looked at and isolated 
in separated care areas.
This study further revealed that most of the respondents 
who would not go back to the ART clinic for review are 
those who would not receive the good care they received 
from service providers as before they were diagnosed 
with HIV (p value 0.002). This was also supported by 
most participants in the focus group discussion who said 
that they would not go back to the ART clinic because of 
the poor attitude of service providers portrayed to them. 
For example, one participant indicated that it was better to 
seek HIV care at a private health facility where they are 
accorded more attention than government health 
facilities.
All these behaviours from health care providers portray 
that HIV associated stigma and discrimination still 
remain a critical problem in most countries for effective 
control of the pandemic. In most instances, this is likely to 
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demoralize the affected individuals who may decide not 
to seek HIV services anymore as another participant in the 
focus group discussion indicated that it was just better to 
die at home. This revelation agrees with the sentiments of 
Nelson Mandela who at the XIV International AIDS 
conference said that stigma, discrimination and ostracism 
6against HIV are the real killers . This finding is indeed 
worrying as the convergence of TB disease and HIV 
infection if untreated can lead to high morbidity and 
mortality rates among those infected with the dual 
epidemics as also documented by the WHO (2006).
Support from Health Care Providers regarding HAART
The study revealed that only 33.3% of the respondents 
had their concerns regarding HAART addressed by health 
care providers while the concerns of 66.7% respondents 
were not addressed. One of the reasons why most of the 
patients concerns related to HAART were not addressed 
could be attributed to poor attitude by health care 
providers towards people co-infected with TB and HIV as 
well as poor attitude towards work. This was also shown 
by the various responses from the participants in the focus 
group discussion. Some participants said that the nurses 
were rude while one participant said that he was told that 
he just didn't want to take the medicine when he asked 
about the side effects. Such an attitude by health care 
providers may have an impact on motivating clients to 
commence HAART as clients may not know what to do in 
case they experience side effects.
Another reason for health workers not addressing the 
patient's concerns may be related to shortage of 
manpower at health facilities. In such circumstances, 
health workers may be more preoccupied with ensuring 
that all the clients are attended to within a shortest period 
of time than devoting their time to addressing the clients' 
concerns which may take a long period of time. Though 
ensuring that clients spend less time at health facilities is 
good, it may not benefit those whose concerns are not met 
as they would not be fully satisfied with the services that 
they receive. This fact was confirmed by Macha (2008) 
who indicated that inadequate human resource in health 
facilities resulted in inefficiency.
Since both TB drugs and ARVs are strong drugs with life 
threatening side effects such as liver toxicity, inability to 
address the concerns regarding HAART for TB/HIV co-
infected patients may limit uptake of HAART by these 
patients. It is noteworthy that the study also revealed an 
association between having the HAART concerns 
addressed and uptake of HAART (p value 0.008). This is 
in line with Eang et al (2007) who reported that 
continuous discussion and education of concerns 
regarding HAART between clients and service providers 
was significantly associated with motivating clients to 
utilize HAART.
Recommendations 
Based on the findings, the researcher recommended that 
the Ministry of Health to adopt an integrated TB and HIV 
service delivery to allow for commitment from the health 
care providers towards treatment and control of the dual 
epidemics. Capacity building in TB and HIV relationship 
for clinicians in the TB centres can easily be initiated so 
7that HAART is commenced in these centres . This report 
indicates that when health care providers are equipped 
with knowledge on TB/HIV co-infection and HAART, 
they will face fewer problems in managing patients 
infected with the dual epidemic. In such circumstances, 
the health care providers will understand the 
consequences of the dual epidemic on patients and thus, 
they are likely to encourage eligible patients to commence 
HAART. On the other hand, the patients will be equipped 
with knowledge on TB/HIV co-infection and HAART 
because the health care providers will impart the 
knowledge to them. Since the consequences of TB/HIV 
co-infection and the benefits of HAART will be 
understood by the patients, uptake of HAART is likely to 
increase.
In addition, the Directly Observed Therapy (DOT) model 
utilized in the TB centres can be utilized to achieve 
superior outcomes among these patients with the dual 
epidemics. Since the DOT model reinforces the 
importance of adherence with anti-TB drugs as well as 
constant information education and communication, the 
model can also allow for its use with ARV therapy when 
treatment for both TB and HIV are provided at one site. In 
an integrated management of TB/HIV co-infected 
patients, a unique opportunity to achieve high rates of 
adherence with ARV therapy while on anti-TB drugs is 
created. This approach may further provide the patient 
with the skills to maintain life-long adherence with ARVs 
once TB therapy is completed. In addition, there will be 
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utilization of other supportive and outreach efforts 
available through the DOT services. Close follow-up of 
patients through the frequent contact required for DOT 
will allow for more careful monitoring of patients to 
promptly identify adverse effects of ARVs, particularly 
during the early phase after initiation of HAART. Trust is 
equally likely to be developed between the patient and 
health care provider leading to free dissemination of 
information relating to TB/HIV co-infection.
Ministry of Health should screen service providers so that 
only those who possess the good qualities of caring for 
clients co-infected with HIV and TB can be allowed to 
practice in the HIV and TB sites. This is because these 
two infections are mostly associated with stigma and 
discrimination. 
There is need for hospitals to work closely with District 
Health Offices and communities to intensify and sustain 
massive education campaigns on the benefits of the 
utilization of HAART by patients co-infected with TB 
and HIV. Various educational strategies such as the use of 
leaflets and brochures should be adopted. Health care 
providers should also identify and involve clients who 
had received concurrent TB therapy and HAART in 
sensitizing and encouraging other clients to also utilize 
HAART while on TB therapy. Stigma including self 
stigma which is due to shame can also be lessened leading 
to increased uptake of HAART while on TB treatment.
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